1-20 of 2308 Search Results for

edema

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000460496
EISBN: 978-3-318-06042-3
... Abstract Intravitreal ranibizumab (RBZ) has been shown in multiple randomized clinical trials to be a valuable treatment for diabetic macular edema (DME), promoting a significant improvement in best-corrected visual acuity (BCVA) and in anatomic outcomes. Compared to sham (RISE and RIDE studies...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000460220
EISBN: 978-3-318-06042-3
... Abstract For decades, macular laser photocoagulation has been the standard of care in the treatment of diabetic macular edema (DME). With the relatively recent advent of anti-vascular endothelial growth factor (VEGF) agents, DME treatment has entered a new era. VEGF is a well-known pro...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459691
EISBN: 978-3-318-06042-3
... Abstract Over the past decade, great strides have been made in the management of diabetic macular edema (DME). Therapeutic alternatives now include focal/grid laser photocoagulation, vitreo-retinal surgery, and intraocular injection of anti-angiogenic and steroid molecules. Intravitreal...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459692
EISBN: 978-3-318-06042-3
... for the treatment of center-involving diabetic macular edema (DME). A total of 854 adult patients with type I or II diabetes and any level of non-proliferative diabetic retinopathy or proliferative retinopathy with adequate panretinal photocoagulation, with best-corrected visual acuity (BCVA) of 78 to 24 ETDRS...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459694
EISBN: 978-3-318-06042-3
... comparing aflibercept, bevacizumab, and ranibizumab as treatment option for center-involving diabetic macular edema (DME). The main outcome measures were change in visual acuity (VA), central subfield thickness (CST) on optical coherence tomography, cost effectiveness, burden of care, and safety. Results...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459696
EISBN: 978-3-318-06042-3
... Abstract Laser treatment was used in the past to reduce the visual loss due to diabetic macular edema. The recent advent of anti-vascular endothelial growth factor (anti-VEGF) has completely revolutionized the management of diabetic retinopathy, with a significant improvement in the overall...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459706
EISBN: 978-3-318-06042-3
... Abstract Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients, and its management is often a long process requiring frequent monitoring and therapeutic interventions. During the past several decades, numerous treatments have been developed for the treatment...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455264
EISBN: 978-3-318-06033-1
... Abstract Macular edema is the result of an accumulation of fluid in the retinal layers around the fovea. It contributes to vision loss by altering the functional cell relationship in the retina and promoting an inflammatory reparative response. Macular edema may be intracellular...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455266
EISBN: 978-3-318-06033-1
... Abstract The macula is predisposed to edema in various retinal conditions, even when the insult is remote from the macula. The various factors that may predispose the macula to edema include high metabolic activity, radial arrangement of the Henle's layer, lack of inner layers at the fovea...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455269
EISBN: 978-3-318-06033-1
... the different layers of the retinal capillary network could be visualized in this bidimensional examination, possibly because of light-scattering phenomena. Nevertheless, morphological findings such as macular edema (ME) may be clearly evaluated on optical coherence tomography angiography (OCTA). Being...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455275
EISBN: 978-3-318-06033-1
... Abstract Macular edema represents the end-stage of multiple pathophysiological pathways in a multitude of ocular vascular, inflammatory, and other diseases. The rationale for clinical treatment of macular edema is based on the understanding and the inhibition of these pathophysiological...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455277
EISBN: 978-3-318-06033-1
... Abstract Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455279
EISBN: 978-3-318-06033-1
... Abstract Macular edema is one of the most common causes of permanent vision loss in patients with uveitis. The current understanding of water balance and metabolism within the retina has given us better insight into the mechanisms underlying macular edema arising from both acute and chronic...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455280
EISBN: 978-3-318-06033-1
... Abstract Cystoid macular edema (CME) is a primary cause of reduced vision following both cataract and successful vitreoretinal surgery. The incidence of clinical CME following modern cataract surgery is 0.1-2.35%. Preexisting conditions such as diabetes mellitus and uveitis as well...
Book Chapter
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455282
EISBN: 978-3-318-06033-1
... Abstract Macular edema is most often clinically defined as an accumulation of serous fluid within the neurosensory retina with increased thickness of the central retina. In exudative age-related macular degeneration the leakage of fluid from the choroidal new vessels may be the origin...
Book
Book Cover Image
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/isbn.978-3-318-06033-1
EISBN: 978-3-318-06033-1
Book Chapter
Series: Developments in Ophthalmology
Volume: 55
Published: 27 October 2015
10.1159/000438970
EISBN: 978-3-318-05565-8
... Abstract Diabetic retinopathy and diabetic macular edema result from chronic damage to the neurovascular structures of the retina. The pathophysiology of retinal damage remains uncertain but includes metabolic and neuroinflammatory insults. These mechanisms are addressed by intensive metabolic...
Book Chapter
Series: Developments in Ophthalmology
Volume: 54
Published: 27 August 2014
10.1159/000360463
EISBN: 978-3-318-02661-0
... Abstract Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME...
Book Chapter
Series: ESASO Course Series
Volume: 4
Published: 27 February 2014
10.1159/000355918
EISBN: 978-3-318-02564-4
... Abstract Today, optical coherence tomography (OCT) has become the first imaging technique in the assessment and management of diabetic macular edema (DME). OCT can diagnose macular edema noninvasively even at a very early stage. OCT is able to demonstrate basic structural changes of the retina...
Book Chapter
Series: ESASO Course Series
Volume: 2
Published: 15 August 2012
10.1159/000338205
EISBN: 978-3-318-02159-2
... in both type 1 and type 2 diabetes. Similarly, tight blood pressure control reduces the risk of retinopathy progression, visual loss, and the need for laser treatment in people with type 2 diabetes. Modified focal/grid argon laser photocoagulation is the standard of care in diabetic macular edema (DME...